Regulations Governing Offshore Structured Products Article 19
Where an offshore structured product is not targeted specifically to professional investors for trust investment or sales, its issuer or master agent shall submit the following documents to the trade association of the trustee or sub-distributor for review, and shall in two (2) business days after receiving the approval notice, report to the FSC for reference:1. A specimen of agreement signed between the issuer or master agent and the trustee or sub-distributor pursuant to Paragraph 1 of Article 16 herein;2. Documents evidencing that the issuer or master agent has posted operating bond as required according to Article 7 herein;3. The investor brochure and prospectus, both in Chinese version, of the offshore structured product;4. A written statement from the offshore structured product issuing institution that it will, at the request of the FSC, provide account books and records related to the purchase and redemption of the offshore structured product, and information related to the rights and interests of investors to the FSC for review;5. The latest CPA-audited financial report of the offshore structured product issuing institution and its Chinese translation, and a statement that the Chinese translation is the same as the original version;6. A document evidencing compliance with the credit rating requirement under these Regulations and a statement of regulatory compliance;7. An opinion letter from an attorney stating that investor protection at the registration places of the offshore structured product-issuing institution and the product are comparable to that offered in Taiwan; and8. Other documents required by the FSC.The Life Insurance Association of the Republic of China (LIA-ROC) may entrust another institution, subject to the consent of the FSC, to conduct the review of offshore structured products sold by insurance companies as specified in the preceding paragraph and file the information with the FSC in accordance with Paragraph 5 hereof.The FSC may order the trust investment in or sale of all or part of a reviewed offshore structured product specified in the preceding two paragraphs to stop if the FSC discovered any of the following situations:1. It disrupts market order;2. It damages the rights or interests of customers;3. It endangers the business and financial health of the financial service firms; or4. Other situations that violate law or regulations.Where an offshore structured product is offered to professional investors only, the trustee or sub-distributor shall conduct review of documents specified in all subparagraphs other than Subparagraph 7 of Paragraph 1 hereof by itself before commencing the trust investment or sales activities. 5. However, regarding the latest CPA-audited financial report of the offshore structured product issuing institution and its Chinese translation as required under Subparagraph 5 of Paragraph 1 hereof, the said Chinese translation may be replaced by a summary Chinese translation covering the CPA's audit opinion, balance sheet, income statement, statement of changes in owners' equity, cash flow statements and those footnotes involving material information.The trade association of the trustee or sub-distributor mentioned in Paragraph 1 hereof shall, before the tenth of each month, compile the information on the number of products that passed the review in the previous month and relevant information and forward the same to the FSC and the Central Bank of the Republic of China (Taiwan).In event that the Chinese investor brochure of Subparagraph 3 of Paragraph 1 or the prospectus of Paragraph 4 is not translated faithfully, the construction of any provisions that are in doubt shall be made in favor of the investor.
中文原文 境外結構型商品管理規則第19條
境外結構型商品非以專業投資人為受託或銷售對象者，其發行人或其總代理人應檢具下列文件送受託或銷售機構所屬同業公會審查，並應於收到審查通過通知書後二個營業日內報請本會備查：
一、發行人或總代理人及受託或銷售機構依第十六條第一項所簽訂之契約範本。
二、發行人或總代理人依第七條規定提存營業保證金之證明文件。
三、境外結構型商品之中文投資人須知及中文產品說明書。
四、境外結構型商品發行機構出具聲明書，聲明將依本會之要求，提供該境外結構型商品投資或贖回等之相關簿冊及涉及投資人權益之相關資料予本會查閱。
五、境外結構型商品之發行機構最近期之經會計師查核簽證之財務報告及其中譯本，並出具其中譯本內容與原文版無異之聲明書。
六、符合本規則所定條件之信用評等證明文件及法規遵循聲明書。
七、律師出具境外結構型商品發行機構及商品註冊地對投資人權益之保護相當於我國之意見書。
八、其他經本會規定應具備之文件。
中華民國人壽保險商業同業公會依前項辦理保險業所銷售境外結構型商品之審查，得經本會同意委託其他機構為之，並依第五項規定向本會申報資料。
本會對於前二項審查通過之境外結構型商品，發現有下列情事之一者，得命令停止該商品全部或一部之受託或銷售：
一、有礙市場秩序。
二、損害客戶權益。
三、危及金融服務業財務健全。
四、其他違反法令之情事。
境外結構型商品限於專業投資人投資者，受託或銷售機構應就第一項除第七款規定以外之各款文件自行審查通過後，始得為受託或銷售之行為。
但第一項第五款應檢具最近期之經會計師查核簽證之原文版財務報告及其中譯本，其中譯本得以中文簡譯本代替，內容包括會計師查核意見中譯本、資產負債表、損益表、股東權益變動表、現金流量表及附註涉及重要資訊部分中譯本。
第一項所定之受託或銷售機構所屬同業公會，應於每月十日前將上月審查通過商品數量及相關資料彙總向本會申報，並副知中央銀行。
第一項第三款及第四項應受審查之中文投資人須知及中文產品說明書未忠實轉譯者，如有疑義，應為最有利於投資人之解釋。
一、發行人或總代理人及受託或銷售機構依第十六條第一項所簽訂之契約範本。
二、發行人或總代理人依第七條規定提存營業保證金之證明文件。
三、境外結構型商品之中文投資人須知及中文產品說明書。
四、境外結構型商品發行機構出具聲明書，聲明將依本會之要求，提供該境外結構型商品投資或贖回等之相關簿冊及涉及投資人權益之相關資料予本會查閱。
五、境外結構型商品之發行機構最近期之經會計師查核簽證之財務報告及其中譯本，並出具其中譯本內容與原文版無異之聲明書。
六、符合本規則所定條件之信用評等證明文件及法規遵循聲明書。
七、律師出具境外結構型商品發行機構及商品註冊地對投資人權益之保護相當於我國之意見書。
八、其他經本會規定應具備之文件。
中華民國人壽保險商業同業公會依前項辦理保險業所銷售境外結構型商品之審查，得經本會同意委託其他機構為之，並依第五項規定向本會申報資料。
本會對於前二項審查通過之境外結構型商品，發現有下列情事之一者，得命令停止該商品全部或一部之受託或銷售：
一、有礙市場秩序。
二、損害客戶權益。
三、危及金融服務業財務健全。
四、其他違反法令之情事。
境外結構型商品限於專業投資人投資者，受託或銷售機構應就第一項除第七款規定以外之各款文件自行審查通過後，始得為受託或銷售之行為。
但第一項第五款應檢具最近期之經會計師查核簽證之原文版財務報告及其中譯本，其中譯本得以中文簡譯本代替，內容包括會計師查核意見中譯本、資產負債表、損益表、股東權益變動表、現金流量表及附註涉及重要資訊部分中譯本。
第一項所定之受託或銷售機構所屬同業公會，應於每月十日前將上月審查通過商品數量及相關資料彙總向本會申報，並副知中央銀行。
第一項第三款及第四項應受審查之中文投資人須知及中文產品說明書未忠實轉譯者，如有疑義，應為最有利於投資人之解釋。